Markets:

Overview

News

Currencies

International

Treasuries

IMV Inc. - Common Shares (NQ:IMV)

N/A UNCHANGED

Last Price Updated: 3:58 PM EDT, Apr 28, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IMV Inc. - Common Shares

< Previous 1 2 3 4 5 Next >

The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗

August 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

IMV Inc. Announces Second Quarter 2021 Financial and Operational Results

August 11, 2021

From IMV Inc.

Via Business Wire

IMV's Shares Jump As Ovarian Cancer Candidate Shows Overall Survival Rate Of 44.9% ↗

August 10, 2021

IMV Inc (NASDAQ: IMV) has announced the final topline results of the DeCidE1 Phase 2 trial evaluating maveropepimut-S (MVP-S, formerly known as DPX-Survivac) for...

Via Benzinga

IMV Announces Final Topline Results of the DeCidE1 Clinical Trial in Advanced Recurrent Ovarian Cancer

August 10, 2021

From IMV Inc.

Via Business Wire

IMV Announces CEO Transition

August 04, 2021

From IMV Inc.

Via Business Wire

IMV Inc. to Announce Second Quarter 2021 Results and Host a Conference Call and Webcast on August 11, 2021

August 02, 2021

From IMV Inc.

Via Business Wire

IMV to Participate in the BTIG Virtual Biotechnology Conference

July 29, 2021

From IMV Inc.

Via Business Wire

44 Stocks Moving In Tuesday's Mid-Day Session ↗

July 27, 2021

Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that...

Via Benzinga

62 Biggest Movers From Yesterday ↗

July 28, 2021

Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced...

Via Benzinga

34 Stocks Moving in Tuesday's Pre-Market Session ↗

July 27, 2021

Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company announced it entered a non-binding letter of intent to...

Via Benzinga

74 Biggest Movers From Yesterday ↗

July 27, 2021

Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with...

Via Benzinga

48 Stocks Moving In Monday's Mid-Day Session ↗

July 26, 2021

Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The...

Via Benzinga

40 Stocks Moving in Monday's Pre-Market Session ↗

July 26, 2021

Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc (NASDAQ: NAOV) shares rose 45.2...

Via Benzinga

IMV Inc. Closes Previously Announced Public Offering

July 20, 2021

From IMV Inc.

Via Business Wire

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗

July 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:...

Via Benzinga

Topics Stocks

54 Biggest Movers From Yesterday ↗

July 16, 2021

Gainers Sight Sciences, Inc. (NASDAQ: SGHT) shares jumped 39.6% to settle at $33.50 on Thursday as the company priced its IPO at $24 per share. Cinedigm Corp. (NASDAQ: CIDM)...

Via Benzinga

Topics Initial Public Offering

Mid-Afternoon Market Update: Nasdaq Drops 100 Points; FVCBankcorp Shares Jump ↗

July 15, 2021

Toward the end of trading Thursday, the Dow traded up 0.11% to 34,973.31 while the NASDAQ fell 0.69% to 14,543.67. The S&P also fell, dropping 0.29% to 4,361.49. The U.S. has...

Via Benzinga

Topics Stocks

Mid-Day Market Update: Crude Oil Down Over 1%; Cinedigm Shares Spike Higher ↗

July 15, 2021

Midway through trading Thursday, the Dow traded down 0.04% to 34,918.42 while the NASDAQ fell 0.52% to 14,568.88. The S&P also fell, dropping 0.30% to 4,361.05. The U.S. has...

Via Benzinga

Topics Stocks

32 Stocks Moving In Thursday's Mid-Day Session ↗

July 15, 2021

Gainers ATA Creativity Global (NASDAQ: AACG) shares jumped 37.8% to $4.1050. Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 20.9% to $3.01. Verb Technology shares...

Via Benzinga

Mid-Morning Market Update: Markets Mostly Lower; Morgan Stanley Tops Q2 Views ↗

July 15, 2021

Following the market opening Thursday, the Dow traded down 0.22% to 34,856.63 while the NASDAQ rose 0.01% to 14,645.82. The S&P also fell, dropping 0.17% to 4,366.76. The U.S...

Via Benzinga

Topics Stocks

IMV Stock Plunges After Raising $25M Via Equity Issued At 16% Discount ↗

July 15, 2021

IMV Inc (NASDAQ: IMV) has priced its previously-announced underwritten public offering of 14.3 million shares at $1.75 per Unit, for gross proceeds of...

Via Benzinga

IMV Inc. Announces Pricing of Public Offering

July 15, 2021

From IMV Inc.

Via Business Wire

IMV Inc. Files Preliminary Prospectus Supplement for Proposed Public Offering of Units

July 14, 2021

From IMV Inc.

Via Business Wire

The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗

July 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test ↗

July 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Topics Product Recall

The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend ↗

July 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 02, 2021

Before 10 a.m. ET on Friday, 43 companies set new 52-week lows. Points of Interest: Autohome (NYSE:ATHM) was the largest firm by market cap to set a new 52-week low...

Via Benzinga

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗

July 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

IMV Inc. - Common Shares (NQ:IMV)

All News about IMV Inc. - Common Shares

Starting at $3.75/week.

Subscribe Today